ABOUT US​

LifeMax is a clinical stage biotech company with seasoned management team that has full-spectrum pharmaceutical industry experience including building a multi-billion US public company from ground up.  The company's mission is to engage in R&D, manufacturing and commercialization of innovative pharmaceutical products that provide meaningful clinical benefit to patients.

R&D

LifeMax' R&D pipeline is focused on diseases that have few or no approved therapeutic options.  Our product selection is based not only on unmet medical needs but also on unmet market need.  Our balanced product portfolio includes mix of NCE’s/NME’s and re-purposing/re-position molecules to balance the development risk.

December 3, 2018 
LifeMax Appoints Kirk Johnson, Ph.D., as VP of Preclinical Development

Palo Alto, California – (Business Wire) – December 03, 2018 – LifeMax Laboratories, Inc. (“LifeMax”), a private company ...

September 13, 2018
LifeMax Appoints Laman Alani, Ph.D., as VP of Product Development

Palo Alto, California – (Business Wire) – September 13, 2018 – LifeMax Laboratories, Inc. (“LifeMax”), a private company ...

August 27, 2018 
LifeMax Acquires Worldwide Right to Clinical Stage Orphan Asset

Palo Alto, California – (Business Wire) - August 27, 2018 – LifeMax Laboratories, Inc. (“LifeMax”), a private company focused on treating diseases with few or no therapeutic ...

NEWS

Treating Orphan Diseases With Few or No Options.

map.png

Redwood City, CA, USA

map.png

Taipei, Taiwan

©2020 BY LIFEMAX HEALTHCARE INTERNATIONAL